T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $935B
1-Year Est. Return 30.3%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Est. Return
1 Year Est. Return
+30.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$883B
AUM Growth
+$71.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,193
New
Increased
Reduced
Closed

Top Buys

1 +$4.95B
2 +$3.48B
3 +$2.66B
4
AMD icon
Advanced Micro Devices
AMD
+$1.92B
5
GE icon
GE Aerospace
GE
+$1.49B

Top Sells

1 +$3.79B
2 +$2.63B
3 +$2.46B
4
FISV
Fiserv Inc
FISV
+$2.19B
5
LLY icon
Eli Lilly
LLY
+$1.78B

Sector Composition

1 Technology 34.76%
2 Financials 12.08%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOC icon
976
Healthpeak Properties
DOC
$11.8B
$17.7M ﹤0.01%
1,013,409
-1,185
EPRT icon
977
Essential Properties Realty Trust
EPRT
$6.07B
$17.6M ﹤0.01%
550,503
-345,837
UDR icon
978
UDR
UDR
$11.6B
$17.5M ﹤0.01%
429,738
-2,548
TNET icon
979
TriNet
TNET
$2.74B
$17.4M ﹤0.01%
237,842
+910
RAPP
980
Rapport Therapeutics
RAPP
$1.41B
$17.3M ﹤0.01%
1,525,519
+452,311
IESC icon
981
IES Holdings
IESC
$8.51B
$17.3M ﹤0.01%
58,469
+991
TRDA icon
982
Entrada Therapeutics
TRDA
$394M
$17.3M ﹤0.01%
2,567,478
-169,289
MRNA icon
983
Moderna
MRNA
$10.8B
$17.2M ﹤0.01%
624,159
-18,789
GLXY
984
Galaxy Digital Inc
GLXY
$4.9B
$17.2M ﹤0.01%
+785,141
NDSN icon
985
Nordson
NDSN
$13.4B
$16.9M ﹤0.01%
78,958
+179
COLB icon
986
Columbia Banking Systems
COLB
$8.43B
$16.9M ﹤0.01%
722,409
+65,115
CHRW icon
987
C.H. Robinson
CHRW
$18.6B
$16.8M ﹤0.01%
175,526
+3,498
ACM icon
988
Aecom
ACM
$13.5B
$16.8M ﹤0.01%
149,056
+12,097
ARCO icon
989
Arcos Dorados Holdings
ARCO
$1.56B
$16.8M ﹤0.01%
2,129,756
-8,404,510
SOFI icon
990
SoFi Technologies
SOFI
$33.5B
$16.7M ﹤0.01%
919,541
+49,778
COHR icon
991
Coherent
COHR
$28.6B
$16.6M ﹤0.01%
186,282
-176,494
ROIV icon
992
Roivant Sciences
ROIV
$14.6B
$16.6M ﹤0.01%
1,471,223
+1,210,181
PLUS icon
993
ePlus
PLUS
$2.37B
$16.6M ﹤0.01%
229,905
+2,732
KMTS
994
Kestra Medical Technologies
KMTS
$1.24B
$16.5M ﹤0.01%
997,196
+147,778
EEFT icon
995
Euronet Worldwide
EEFT
$3.14B
$16.5M ﹤0.01%
162,728
-323,698
SWKS icon
996
Skyworks Solutions
SWKS
$10.3B
$16.5M ﹤0.01%
221,321
-9,410
BLCO icon
997
Bausch + Lomb
BLCO
$5.96B
$16.3M ﹤0.01%
1,249,313
-32,587
CPRX icon
998
Catalyst Pharmaceutical
CPRX
$2.89B
$16M ﹤0.01%
735,698
-241,925
PAYC icon
999
Paycom
PAYC
$9.1B
$15.9M ﹤0.01%
68,593
-1,028
BG icon
1000
Bunge Global
BG
$18.1B
$15.8M ﹤0.01%
196,604
-4,373